PMCTPharmaCountry
    Home

Analysis

In-depth analysis of pharmaceutical markets, supply chains, technology and regulation

#1635 ×

Analysis
Sep 17, 2026•1 min read
Asia Becomes New Hub for Global New‑Drug Development
Asia’s biotech ecosystem, bolstered by government investment and regulatory reforms, now accounts for about 43% of the global innovative therapy pipeline, shifting R&D focus from the US and Europe.